CAXTON CORP portfolio

Q2 2022 · Holdings as of 30 Jun 2022 · Filed 15 Aug 2022 · $46,032,000 reported in Form 13F

All quarters Options holdings View SEC source

Save to watchlist Sign in to save

What changed in Q2 2022?

Comparable share positions since Q1 2022.

View all holdings

New: 1
Increased: 3
Reduced: 0
Exited: 23

Largest disclosed changes

PSTH Exited
PERSHING SQUARE TONTINE HLDG

-227,000 shares

-$4,515,000 estimated

Weight -5.61 percentage points
ADXN Exited
ADDEX THERAPEUTICS LTD

-265,940 shares

-$1,351,000 estimated

Weight -1.68 percentage points
GOOG Exited
ALPHABET INC

-395 shares

-$1,104,000 estimated

Weight -1.37 percentage points
VECT New
VECTIVBIO HLDG AG

194,577 shares

+$1,051,000 estimated

Weight +2.28 percentage points
MSFT Exited
MICROSOFT CORP

-3,263 shares

-$1,006,000 estimated

Weight -1.25 percentage points

Estimates use share changes and filing prices. They are not trade proceeds. Options and principal positions are excluded.

Compare with Q1 2022

Holdings

Show detailed columns

Sym	Weight	Trade Impact	Company	Class	Share Change	Activity	Value change	SEC-reported value	SEC-reported price	Shares	Principal

Filing details and SEC source

Portfolio date: 30 Jun 2022
Reported 13F value: $46,032,000
Reported 13F holdings: 15
Largest 13F holdings: SVRA XERS GLD SPY RZLT SCYX MTEM ACLX VECT EIGR ELEV BTWNW
+3 more
LUXAW PVWS FLACW
What this filing covers: Period
Q2 2022
Calendar quarter covered by the filing.
13F holdings
15
Parsed equity rows, excluding option-only view rows.
Reported value
$46,032,000
SEC Form 13F market value, not total AUM.
Accepted by SEC
12 Aug 2022
EDGAR acceptance date.
How to read this filing
Start with the largest positions and changes, then open issuer-level rows for CUSIP-specific history.
Form 13F market value excludes cash and many non-13F assets, so it should not be treated as total assets under management.
SEC classifies this as a holdings report: this manager reports its visible U.S.-listed equity holdings in this filing.
<strong>Confidential Treatment Requested</strong> (one or more holding(s) omitted).
Manager signature: Heath Weisberg - Chief Compliance Officer
Manager location: Princeton, NJ
Accepted by SEC: 12 Aug 2022, 17:57:49 UTC
SEC form: 13F-HR
Prior SEC filing: Q1 2022 - 16 May 2022
Next SEC filing: Q3 2022 - 14 Nov 2022
Source filing: View source filing
Options holdings: Showing equity holdings. Open options holdings.

This view compares filing 2022 Q2 with 2022 Q1. Changes are calculated against the previous SEC filing.

Compare Q2 2022 to

SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held.
^* marks a reported price that did not pass the local price check.

Confidential Treatment Requested. (The Manager has omitted from this public Form 13F one or more holding(s) for which it is requesting confidential treatment from the U.S. Securities and Exchange Commission pursuant to section 13(f) of the Exchange Act and rule 24b-2 thereunder)

Person Signing this Report on Behalf of Reporting Manager:

Name	Title	City, State	Date
Heath Weisberg	Chief Compliance Officer	Princeton, New Jersey	12 Aug 2022